There are 3161 resources available
1224P - Evaluation of safety and feasibility of adjuvant chemotherapy in elderly patients with primary non-small cell lung cancer
Presenter: Alice MOGENET
Session: Poster session 04
1225P - Perioperative serplulimab and chemotherapy in patients with resectable squamous non-small cell lung cancer: An open-label, single-arm, phase II trial
Presenter: Haiquan Chen
Session: Poster session 04
1226P - Predictive value of circulating tumor DNA (ctDNA) before and shortly after curative treatment in early stage non-small cell lung cancer (NSCLC), and exploration of (pre-)analytical factors
Presenter: Michel van den Heuvel
Session: Poster session 04
1227P - Update on the analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1
Presenter: Maria Sereno
Session: Poster session 04
1228P - Association between air pollution and frequency of driver mutation among a Hispanic population with lung cancer
Presenter: Mateo Tamayo
Session: Poster session 04
Resources:
Abstract
1229P - Precision patient selection for postoperative therapy in resectable NSCLC: A comprehensive postoperative-risk model incorporating genetic and histological features
Presenter: Yuanzi Ye
Session: Poster session 04
1230P - Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study
Presenter: Mariano Provencio Pulla
Session: Poster session 04
1231P - Clinical characteristics and real-world treatment patterns in stage I-III resectable NSCLC: THASSOS-INTL study
Presenter: Kumar Prabhash
Session: Poster session 04
1233P - Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC
Presenter: Apostolos Klinakis
Session: Poster session 04